Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Woodline Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 47
Average round size
info
The average size of a deal this fund participated in
$154M
Portfolio companies 43
Rounds per year 7.83
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 16
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Woodline Partners:
Typical Co-investors
Woodline Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Woodline Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
415 CAPITAL Management Bavaria, Germany, Oberhaching
Black Horse Capital Advisors -
Dingxiang Capital Beijing, Beijing, China
East Africa Capital Partners Kenya, Nairobi, Nairobi Area
Framgia -
Glengary Ventures Beachwood, Ohio, United States
Guoqian Venture Capital China, Haimen, Jiangsu
Heyihui Capital Beijing, Beijing, China
Huashan Touzi Beijing, Beijing, China
Just Eat England, London, United Kingdom
Kiraboshi Bank Chiyoda, Japan
MedCity News Cleveland, Ohio, United States
Mobai Capital China, Guangdong, Guangzhou
Patni Group India, Maharashtra, Mumbai
Pittsburgh Equity Partners Pennsylvania, Pittsburgh, United States
Swedbank Lithuania, Vilniaus Apskritis, Vilnius
Telekom Investment Pool -
Zedcrest Capital Limited Lagos, Lagos, Nigeria

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Obsidian Therapeutics

Biotechnology
Health Care
Pharmaceutical
$160M03 Apr 2024 Cambridge, Massachusetts, United States

Mirador Therapeutics

$400M21 Mar 2024 San Diego, California, United States

Odyssey Therapeutics

Biotechnology
Health Care
$101M05 Dec 2023 Cambridge, Massachusetts, United States

Septerna

Biotechnology
$150M11 Jul 2023 San Francisco, California, United States

Odyssey Therapeutics

Biotechnology
Health Care
$168M13 Oct 2022 Cambridge, Massachusetts, United States

Odyssey Therapeutics

Biotechnology
Health Care
$218M07 Dec 2021 Cambridge, Massachusetts, United States

Arbor Biotechnologies

Biopharma
Biotechnology
Life Science
$215M09 Nov 2021 Cambridge, Massachusetts, United States

Cedilla Therapeutics

Biotechnology
Health Care
Therapeutics
$25M25 Oct 2021 Cambridge, Massachusetts, United States

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$100M20 Oct 2021 Shanghai, China
News
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.

News aggregator SmartNews raises $230 million, valuing its business at $2 billion

– SmartNews, a news aggregation website and app, raised $230m in Series F funding.
– The round was led by Princeville Capital and Woodline Partners, and joined by JIC Venture Growth Investments, Green Co-Invest Investment, and Yamauchi-No.10 Family Office in Japan.
– Existing investors participated in this round including ACA Investments and SMBC Venture Capital.
– The company plans to develop more features for its U.S. audience that will focus on consumer health and safety.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Woodline Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 47
Average round size 154M
Rounds per year 7.83
Peak activity year 2021
Lead investments 1
Follow on index 0.09
Exits 16
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Obsidian Therapeutics

Biotechnology
Health Care
Pharmaceutical
$160M03 Apr 2024 Cambridge, Massachusetts, United States

Mirador Therapeutics

$400M21 Mar 2024 San Diego, California, United States

Odyssey Therapeutics

Biotechnology
Health Care
$101M05 Dec 2023 Cambridge, Massachusetts, United States

Septerna

Biotechnology
$150M11 Jul 2023 San Francisco, California, United States

Odyssey Therapeutics

Biotechnology
Health Care
$168M13 Oct 2022 Cambridge, Massachusetts, United States

Odyssey Therapeutics

Biotechnology
Health Care
$218M07 Dec 2021 Cambridge, Massachusetts, United States

Arbor Biotechnologies

Biopharma
Biotechnology
Life Science
$215M09 Nov 2021 Cambridge, Massachusetts, United States

Cedilla Therapeutics

Biotechnology
Health Care
Therapeutics
$25M25 Oct 2021 Cambridge, Massachusetts, United States

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$100M20 Oct 2021 Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: